Agenda Link: Day 2
DAY 1
TUESDAY, JUNE 27, 2017
JOINT PLENARY SESSION WITH THE MEDICAL AFFAIRS COMPLIANCE SUMMIT
1:00 pm
Welcome and Keynote Address: The Politics and Policy Issues of the Pharmaceutical Marketplace
Susan Dentzer
President and Chief Executive Officer, The Network for Excellence in Health Innovation (NEHI); Analyst on Health Policy, The News Hour, Washington, DC
President and Chief Executive Officer, The Network for Excellence in Health Innovation (NEHI); Analyst on Health Policy, The News Hour, Washington, DC
1:30 pm
View from the Marketplace: Rewarding Results: Moving Forward for Value-Based Contracting for Biopharmaceuticals
Catherine Davis Ahmed, MBA
Director of Policy and Outreach, Familial Hypercholesterolemia Foundation, Washington, DC
Director of Policy and Outreach, Familial Hypercholesterolemia Foundation, Washington, DC
Jim Clement, MHA
Executive Director, Cost of Care & Supply Chain Strategy, Aetna; Former National Account Manager, PBMs & Specialty Pharmacy, Genentech, Inc.; Former Director, Pharmaceutical Contracting, Express Scripts, Inc., Hartford, CT
Executive Director, Cost of Care & Supply Chain Strategy, Aetna; Former National Account Manager, PBMs & Specialty Pharmacy, Genentech, Inc.; Former Director, Pharmaceutical Contracting, Express Scripts, Inc., Hartford, CT
David Hartenbaum, MD, MBA
Executive Director, Account Management, Merck, Philadelphia, PA
Executive Director, Account Management, Merck, Philadelphia, PA
Dorothy Hoffman, MPP (Invited)
Director, Healthcare Transformation and Policy Partnerships, Eli Lilly and Company, Indianapolis, IN
Director, Healthcare Transformation and Policy Partnerships, Eli Lilly and Company, Indianapolis, IN
Surya Singh, MD
Executive Vice President and Chief Medical Officer, CVS/Specialty, Boston, MA
Executive Vice President and Chief Medical Officer, CVS/Specialty, Boston, MA
Susan Dentzer
President and Chief Executive Officer, The Network for Excellence in Health Innovation (NEHI); Analyst on Health Policy, The News Hour, Washington, DC (Moderator)
President and Chief Executive Officer, The Network for Excellence in Health Innovation (NEHI); Analyst on Health Policy, The News Hour, Washington, DC (Moderator)
2:45 pm
A Prosecutor’s Perspective
Gregg Shapiro, JD
Assistant US Attorney, US Attorney’s Office, District of Massachusetts, Boston, MA
Assistant US Attorney, US Attorney’s Office, District of Massachusetts, Boston, MA
3:30 pm
Networking Break
4:00 pm
PhRMA’s Perspective on Public Policy Considerations for Expanding Value-Based Contracting
Michelle Drozd, ScM
Deputy Vice President, Policy and Research, Pharmaceutical Research & Manufacturers of America (PhRMA), Washington, DC
Deputy Vice President, Policy and Research, Pharmaceutical Research & Manufacturers of America (PhRMA), Washington, DC
Julie Ritchie Wagner, JD
Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services, Washington, DC
Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services, Washington, DC
4:45 pm
Recent FDA Draft Guidances on Manufacturer Communications and the Memorandum on Off-Label Communications
Kellie B. Combs, JD
Partner, Ropes & Gray, Washington, DC
Partner, Ropes & Gray, Washington, DC
5:30 pm
Pre-Approval Information Exchange with Payors
Soumi Saha, JD, PharmD
Assistant Director of Pharmacy and Regulatory Affairs, Academy of Managed Care Pharmacy (AMCP); Former Director of National Pharmacy Controls, Kaiser Permanente, Alexandria, VA
Assistant Director of Pharmacy and Regulatory Affairs, Academy of Managed Care Pharmacy (AMCP); Former Director of National Pharmacy Controls, Kaiser Permanente, Alexandria, VA
6:00 pm
Adjournment and Networking Reception
Agenda Link: Day 2